Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines
Type
Retraction
Notice date
6/30/2015 0:00
Journal
Molecular Pharmacology
Publisher
ASPET: American Society for Pharmacology and Experimental Therapeutics